While the wide expression of ADAM10 in normal tissues could undermine such an approach [37], we previously showed preferential binding of our antibody, 8C7, to active ADAM10 which was upregulated in tumours compared to normal tissues, both in mice and in human samples [20]. This evidence concerns the gene ADAM10 and neoplasm.